What You Should Know:
– HealthEx, a new healthcare technology company, has emerged from stealth mode with $14M in Seed and Series A funding.
– The company, hatched by General Catalyst with participation from Electric Capital, is building a global consumer preference and consent platform designed to simplify and streamline data access in healthcare.
Transforming Consent Management with AI
In today’s data-driven healthcare landscape, patients and healthcare organizations face increasing challenges in managing and accessing sensitive health information. Complex consent processes, lengthy legal documents, and evolving regulations create barriers to efficient and compliant data sharing. The platform offers:
- AI-Generated Consents: Assists clinical staff in generating customized consent forms for various use cases.
- Granular Consent Enforcement: Enables data and compliance administrators to programmatically enforce specific consent preferences.
- AI-Assisted Risk Assessments: Provides automated risk assessments of existing consents to ensure compliance with data policies.
- Secure Data Exchange: Facilitates secure data sharing through APIs, gateways, and data vaults.
“As healthcare organizations face new complexities in data use and licensing, it’s clear that both patients and providers need a more streamlined, transparent solution to ensure trust and compliance in today’s data-driven landscape,” said Priyanka Agarwal, MD, MBA, co-founder and CEO of HealthEx and a healthcare veteran with experience in clinical medicine, digital health, and the life sciences. “We allow healthcare organizations to manage this data effectively while giving patients more control over their healthcare decisions and creating a more transparent process. Our vision is to manage patient preferences and consent for individuals across every healthcare touchpoint with a unified experience for preferences, consent, and data access management.”
